Yihan Li
Stock Analyst at Barclays
(2.81)
# 2,864
Out of 4,662 analysts
41
Total ratings
75%
Success rate
13.5%
Average return
Main Sectors:
Stocks Rated by Yihan Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: IPN Ipsen S.A. | Maintained: Hold | €170.00 | €165.10 | +2.97% | 13 | Jul 1, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $88 → $66 | $50.00 | +32.82% | 2 | May 11, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 155.00 | CHF 170.95 | -9.33% | 21 | Dec 8, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 375.00 | kr 292.75 | +28.10% | 2 | Nov 28, 2025 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 275.00 | CHF 367.40 | -25.15% | 3 | Oct 24, 2025 |
Ipsen S.A.
Jul 1, 2026
Maintained: Hold
Price Target: €170.00
Current: €165.10
Upside: +2.97%
Zealand Pharma A/S
May 11, 2026
Maintained: Buy
Price Target: $88 → $66
Current: $50.00
Upside: +32.82%
Galderma Group AG
Dec 8, 2025
Maintained: Buy
Price Target: CHF 155.00
Current: CHF 170.95
Upside: -9.33%
Novo Nordisk A/S
Nov 28, 2025
Maintained: Hold
Price Target: kr 375.00
Current: kr 292.75
Upside: +28.10%
Roche Holding AG
Oct 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: CHF 367.40
Upside: -25.15%